Study on the effect of Risk-Reducing Salpingo-oophorectomy in hereditary breast and ovarian cancer

Study on the effect of Risk-Reducing Salpingo-oophorectomy in hereditary breast and ovarian cancer - Risk-reducing Salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023187

Enrollment

Registered

2016-07-19

Start date

2016-07-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary breast and ovarian caccer

Interventions

surgical treatment (Risk-reducing Salpingo-oophorectomy)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: BRCA1 and BRCA2 mutation carrier

Exclusion criteria

Exclusion criteria: BRCA1 and BRCA2 gene mutation negative case

Design outcomes

Primary

Measure	Time frame
The Preventing treatment of the ovarian cancer high risk case (BRCA1 and BRCA2 mutation carrier)	—

Countries

Japan

Contacts

Public ContactYuuko Yokohama

Asahikawa Medical University Department of Gynecology

yukoy@asahikawa-med.ac.jp0166-68-2562

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026